Cooperative Agreement U01DP006892
Award Date
9/30/24
Completion Date
9/29/29
Dollars Obligated
$500K
Funding Federal Agency
National Center for Chronic Disease Prevention and Health Promotion
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.135
Assistance Type
Cooperative Agreement
Place of Performance
New York, USA
Similar Awards
The Regents of the University of California, San Francisco (UCSF) was awarded a $1,391,384 Cooperative Agreement by the National Center for Chronic Disease Prevention and Health Promotion, a division of the Centers for Disease Control and Prevention (CDC), under the CDC's Centers for Research and Demonstration for Health Promotion and Disease Prevention program (CFDA 93.135). The award will fund the development and evaluation of novel telehealth technologies to detect and manage glaucoma and...
The National Center for Chronic Disease Prevention and Health Promotion, part of the Centers for Disease Control and Prevention (CDC), awarded a $1,500,000 Cooperative Agreement (CFDA 93.135 - Centers for Research and Demonstration for Health Promotion and Disease Prevention) to the University of Alabama at Birmingham (UAB) to implement an AI-based glaucoma screening program within Federally Qualified Health Centers. This 5-year award (9/30/2024 - 9/29/2029) will support UAB in designing,...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $810,000 Cooperative Agreement to the Massachusetts Eye and Ear Infirmary under CFDA Program 93.283 - CDC Investigations and Technical Assistance. The grant, titled "The Glaucoma and Retinopathy Screening Study", supports research and technical assistance to state and local health authorities for controlling communicable diseases, chronic diseases, and other preventable health conditions. The 5-year project, commencing...
The University of Michigan was awarded a $1,500,000 Cooperative Agreement by the Centers for Disease Control and Prevention (CDC) under the "Centers for Research and Demonstration for Health Promotion and Disease Prevention" program (CFDA 93.135). The award, titled "Michigan Screening and Intervention for Glaucoma and Eye Health through Telemedicine (MI-SIGHT) Program: A Pragmatic Randomized Trial", will fund a 5-year project to develop and evaluate a telemedicine-based...
The National Eye Institute (NEI) awarded a $1,448,874 Cooperative Agreement grant under the Vision Research program (CFDA 93.867) to The Regents of the University of California, San Francisco (UCSF) to extend the Village-Integrated Eye Worker Trial II (VIEW II) study. The goal of this 5-year extension project is to determine if a community-based eye disease screening intervention can effectively prevent vision loss in Nepal over a 7-year period. The screening involves using optical coherence...
This National Eye Institute (NEI) Project Grant award (CFDA 93.867 - Vision Research) for $715,098 aims to enhance glaucoma risk prediction through advanced genomics and machine learning techniques. The key products and services to be delivered under this 5-year project include: Improving polygenic risk score (PRS) performance for glaucoma by leveraging enhanced electronic health record (EHR) data phenotyping using natural language processing (NLP) on over 68,000 patient records across two...
Aisight Health Inc. received a $479,580 Project Grant award from the National Institutes of Health's National Eye Institute to develop artificial intelligence tools to identify rapid glaucoma progression. The goal is to use machine learning models trained on over a decade of optical coherence tomography images, visual field tests, and clinical records for more than 9,000 glaucoma patients to more accurately and quickly determine which patients are likely to experience rapid vision loss from...
This Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) provides $628,531 to the University of Miami to validate and implement an artificial intelligence (AI) machine-to-machine (M2M) model for equitable glaucoma screening in underserved populations. The key objectives are to: 1) refine the M2M model using large clinic and population-based datasets to ensure effective and equitable glaucoma screening across diverse groups; 2) implement the M2M model for...
This $4,428,000.00 Cooperative Agreement award, issued by the Centers for Disease Control and Prevention (CDC) under the Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health program (CFDA 93.421), supports the establishment of a Regional Center for Public Health Preparedness and Response in Region 2. The award, with a period of performance from September 30, 2024 to September 29, 2029, will enable The Trustees of Columbia...
This $241,500 Project Grant award from the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) will evaluate the impact of patient, neighborhood, and community characteristics on screening and monitoring adherence for diabetic retinopathy (DR) among Medicare beneficiaries with diabetes. The study aims to 1) identify factors associated with adherence to recommended DR screening intervals, and 2) identify factors associated with adherence to recommended DR...